<p>National HealthCare (NHC) 剛剛公佈了第三季度業績，強調收入增長但淨收入相比去年有所下降。除了財報外，公司還重申了對股東的季度分紅。</p>
<p>查看我們對 National HealthCare 的最新分析。</p>
<p>National HealthCare 的股價在近期表現出令人印象深刻的短期動能，在過去 90 天內上漲了近 27%，儘管其一年期的總股東回報仍略顯負面。近期的財報和持續的分紅記錄無疑吸引了市場的關注，暗示長期的樂觀情緒正在迴歸。</p>
<p>如果強勁的分紅歷史引起了你的興趣，你可能想看看該行業還有什麼其他動態。探索完整列表，免費查看。</p>
<p>隨着近期股價的急劇反彈，投資者需要權衡 National HealthCare 是否仍然以有吸引力的價值交易，或者近期的表現是否意味着市場現在已經完全定價未來的增長潛力。</p>
<h2>最受歡迎的敍述：29% 被低估</h2>
<p>根據 DanielGC 的分析，目前的股價遠低於他們計算的公允價值，暗示如果關鍵假設成立，可能會出現可觀的機會。股票當前交易價格與這一更大膽目標之間的差距，為那些超越最新業績的投資者提供了一個引人注目的故事。</p>
<blockquote>
<p><em>這一敍述探討了市場因短期問題而錯誤定價 NHC 的觀點，創造了一個有吸引力的入場點。我們假設公司將恢復其淨收入，市場將重新評估其估值。</em></p>
</blockquote>
<p>閲讀完整敍述。</p>
<p>好奇哪些變量可能迅速提升 NHC 的估值？這一公允價值背後的關鍵驅動因素絕非普通。發現哪些備受期待的財務里程碑和市場重新定價可能將今天的價格轉變為引人注目的價值。想了解背後的數學故事嗎？繼續閲讀，看看什麼可能會讓你感到驚訝。</p>
<p><strong>結果：公允價值為 179.80 美元（被低估）</strong></p>
<p>完整閲讀敍述，瞭解預測背後的原因。</p>
<p>然而，利潤率的持續下降或收購整合的困難可能會挑戰投資者所期待的重新估值故事。</p>
<p>瞭解 National HealthCare 敍述的關鍵風險。</p>
<h2>另一種觀點：DCF 視角</h2>
<p>雖然基於倍數的估值將 National HealthCare 視為被低估，但我們的 DCF 模型表明市場可能忽視了一個更大的差距。根據 SWS DCF 模型，NHC 的股票交易價格遠低於其公允價值。這是否意味着更深層次的機會，還是僅僅顯示出對公允價值的看法差異如此之大？</p>
<p>深入瞭解 SWS DCF 模型如何得出其公允價值。</p>
<p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/08207d1b-f240-47ba-b645-b73c1ac8fa56/chart/dcf?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/08207d1b-f240-47ba-b645-b73c1ac8fa56/chart/dcf"/></p>
<p>截至 2025 年 11 月的 NHC 折現現金流</p>
<h2>構建你自己的 National HealthCare 敍述</h2>
<p>如果你有自己的觀點或喜歡親自深入數字，構建個人敍述只需幾分鐘，何不按照自己的方式來呢？</p>
<p>你進行 National HealthCare 研究的一個很好的起點是我們的分析，強調了 2 個關鍵獎勵和 1 個重要警示信號，這可能會影響你的投資決策。</p>
<h2>尋找更多投資想法？</h2>
<p>聰明的投資者不會在場邊等待下一個大事件。利用以下精心挑選的篩選器，抓住符合你目標的新機會。</p>
<ul>
<li>通過查看這些 870 只基於現金流的被低估股票，發現潛在的市場錯誤定價。在這裏，你會找到基於強勁現金流基本面的公司。</li>
<li>通過瞄準這些收益率超過 3% 的 16 只分紅股票，最大化你的收入追求，這些股票提供可靠的收益率，並且歷史上分紅穩定。</li>
<li>通過這些 24 只 AI 便士股票，進入快速發展的人工智能世界，提前發現新興技術領導者。</li>
</ul>
<p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也不考慮你的目標或財務狀況。我們的目標是為你提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>

National醫療

<p>National 醫療（NHC）在第三季度報告了更高的收入但淨收入下降，重申了其季度股息。儘管過去 90 天股價上漲近 27%，但一年期回報略顯負面。分析師認為 NHC 被低估，公允價值估計為 179.80 美元，顯示出潛在的增長空間。然而，利潤率下降和收購挑戰等風險可能會影響這一前景。折現現金流模型（DCF）也表明顯著低估，突顯了對公允價值的不同看法。文章強調在做出投資決策之前進行全面分析的重要性</p>

<p>National HealthCare (NHC) just reported its third quarter results, highlighting higher revenue but a dip in net income compared to last year. Along with its earnings, the company also reaffirmed its quarterly dividend for shareholders.</p>
<div class="lb-trans"><p>National HealthCare (NHC) 剛剛公佈了第三季度業績，強調收入增長但淨收入相比去年有所下降。除了財報外，公司還重申了對股東的季度分紅。</p>
</div><p>See our latest analysis for National HealthCare.</p>
<div class="lb-trans"><p>查看我們對 National HealthCare 的最新分析。</p>
</div><p>National HealthCare’s share price has shown impressive near-term momentum, climbing almost 27% over the past 90 days, even as its one-year total shareholder return remains slightly negative. Recent earnings and its consistent dividend track record have certainly caught the market’s attention, hinting at renewed optimism for the long term.</p>
<div class="lb-trans"><p>National HealthCare 的股價在近期表現出令人印象深刻的短期動能，在過去 90 天內上漲了近 27%，儘管其一年期的總股東回報仍略顯負面。近期的財報和持續的分紅記錄無疑吸引了市場的關注，暗示長期的樂觀情緒正在迴歸。</p>
</div><p>If strong dividend histories pique your interest, you might want to see what else is happening in the sector. Explore See the full list for free..</p>
<div class="lb-trans"><p>如果強勁的分紅歷史引起了你的興趣，你可能想看看該行業還有什麼其他動態。探索完整列表，免費查看。</p>
</div><p>With shares rebounding sharply in recent months, investors are left to weigh whether National HealthCare is still trading at an attractive value, or if recent performance means the market is now fully pricing in future growth potential.</p>
<div class="lb-trans"><p>隨着近期股價的急劇反彈，投資者需要權衡 National HealthCare 是否仍然以有吸引力的價值交易，或者近期的表現是否意味着市場現在已經完全定價未來的增長潛力。</p>
</div><h2>Most Popular Narrative: 29% Undervalued</h2>
<div class="lb-trans"><h2>最受歡迎的敍述：29% 被低估</h2>
</div><p>According to DanielGC, the current share price is well below their calculated fair value, hinting at what could be a substantial opportunity if key assumptions play out. The gap between where the stock trades today and this bolder target sets up a compelling story for investors who look beyond the latest results.</p>
<div class="lb-trans"><p>根據 DanielGC 的分析，目前的股價遠低於他們計算的公允價值，暗示如果關鍵假設成立，可能會出現可觀的機會。股票當前交易價格與這一更大膽目標之間的差距，為那些超越最新業績的投資者提供了一個引人注目的故事。</p>
</div><blockquote>
<p><em>This narrative explores the perspective that the market is mispricing NHC due to a short-term issue, creating an attractive entry point. We assume the company will recover its net income and the market will re-rate its valuation.</em></p>
</blockquote>
<div class="lb-trans"><blockquote>
<p><em>這一敍述探討了市場因短期問題而錯誤定價 NHC 的觀點，創造了一個有吸引力的入場點。我們假設公司將恢復其淨收入，市場將重新評估其估值。</em></p>
</blockquote>
</div><p>Read the complete narrative.</p>
<div class="lb-trans"><p>閲讀完整敍述。</p>
</div><p>Curious which variables could ramp up NHC’s valuation fast? The key drivers behind this fair value are far from ordinary. Discover which much-anticipated financial milestones and market reratings could transform today’s price into a value that turns heads. Want the full story behind the math? Read on and see what might surprise you most.</p>
<div class="lb-trans"><p>好奇哪些變量可能迅速提升 NHC 的估值？這一公允價值背後的關鍵驅動因素絕非普通。發現哪些備受期待的財務里程碑和市場重新定價可能將今天的價格轉變為引人注目的價值。想了解背後的數學故事嗎？繼續閲讀，看看什麼可能會讓你感到驚訝。</p>
</div><p><strong>Result: Fair Value of $179.80 (UNDERVALUED)</strong></p>
<div class="lb-trans"><p><strong>結果：公允價值為 179.80 美元（被低估）</strong></p>
</div><p>Have a read of the narrative in full and understand what's behind the forecasts.</p>
<div class="lb-trans"><p>完整閲讀敍述，瞭解預測背後的原因。</p>
</div><p>However, a sustained drop in margins or tougher integration of acquisitions could challenge the revaluation story that investors are hoping for.</p>
<div class="lb-trans"><p>然而，利潤率的持續下降或收購整合的困難可能會挑戰投資者所期待的重新估值故事。</p>
</div><p>Find out about the key risks to this National HealthCare narrative.</p>
<div class="lb-trans"><p>瞭解 National HealthCare 敍述的關鍵風險。</p>
</div><h2>Another View: The DCF Perspective</h2>
<div class="lb-trans"><h2>另一種觀點：DCF 視角</h2>
</div><p>While the multiples-based valuation presents National HealthCare as undervalued, our DCF model indicates the market might be overlooking an even larger gap. According to the SWS DCF model, NHC's shares are trading well below their fair value. Could this signal a deeper opportunity, or does it show just how widely opinions on fair value can differ?</p>
<div class="lb-trans"><p>雖然基於倍數的估值將 National HealthCare 視為被低估，但我們的 DCF 模型表明市場可能忽視了一個更大的差距。根據 SWS DCF 模型，NHC 的股票交易價格遠低於其公允價值。這是否意味着更深層次的機會，還是僅僅顯示出對公允價值的看法差異如此之大？</p>
</div><p>Look into how the SWS DCF model arrives at its fair value.</p>
<div class="lb-trans"><p>深入瞭解 SWS DCF 模型如何得出其公允價值。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/08207d1b-f240-47ba-b645-b73c1ac8fa56/chart/dcf" alt="" original-src="https://images.simplywall.st/company/08207d1b-f240-47ba-b645-b73c1ac8fa56/chart/dcf"/></p>
<p>NHC Discounted Cash Flow as at Nov 2025</p>
<div class="lb-trans"><p>截至 2025 年 11 月的 NHC 折現現金流</p>
</div><h2>Build Your Own National HealthCare Narrative</h2>
<div class="lb-trans"><h2>構建你自己的 National HealthCare 敍述</h2>
</div><p>If you’ve got your own perspective or like diving into the numbers firsthand, crafting a personal narrative takes just a few minutes, so why not Do it your way?</p>
<div class="lb-trans"><p>如果你有自己的觀點或喜歡親自深入數字，構建個人敍述只需幾分鐘，何不按照自己的方式來呢？</p>
</div><p>A great starting point for your National HealthCare research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.</p>
<div class="lb-trans"><p>你進行 National HealthCare 研究的一個很好的起點是我們的分析，強調了 2 個關鍵獎勵和 1 個重要警示信號，這可能會影響你的投資決策。</p>
</div><h2>Looking for more investment ideas?</h2>
<div class="lb-trans"><h2>尋找更多投資想法？</h2>
</div><p>Smart investors don’t wait on the sidelines for the next big thing. Seize new opportunities that match your goals using these handpicked screens below.</p>
<div class="lb-trans"><p>聰明的投資者不會在場邊等待下一個大事件。利用以下精心挑選的篩選器，抓住符合你目標的新機會。</p>
</div><ul>
<li>Uncover potential market mispricings by checking out these 870 undervalued stocks based on cash flows. Here, you’ll find companies that stand out based on strong cash flow fundamentals.</li>
<li>Maximize your pursuit of income by targeting these 16 dividend stocks with yields &gt; 3%, which offers reliable yields above 3% and historically consistent payouts.</li>
<li>Tap into the surging world of artificial intelligence with these 24 AI penny stocks to spot emerging technology leaders before others catch on.</li>
</ul>
<div class="lb-trans"><ul>
<li>通過查看這些 870 只基於現金流的被低估股票，發現潛在的市場錯誤定價。在這裏，你會找到基於強勁現金流基本面的公司。</li>
<li>通過瞄準這些收益率超過 3% 的 16 只分紅股票，最大化你的收入追求，這些股票提供可靠的收益率，並且歷史上分紅穩定。</li>
<li>通過這些 24 只 AI 便士股票，進入快速發展的人工智能世界，提前發現新興技術領導者。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>這篇文章由 Simply Wall St 撰寫，內容具有一般性。<strong>我們提供基於歷史數據和分析師預測的評論，僅使用無偏見的方法，我們的文章並不構成財務建議。</strong> 它不構成買入或賣出任何股票的推薦，也不考慮你的目標或財務狀況。我們的目標是為你提供以基本數據驅動的長期分析。請注意，我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中沒有持倉。</em></p>
</div>

探討 National Healthcare (NHC) 在第三季度業績公佈後的估值及其持續的股息承諾